Cloricromene inhibits the activation of human platelets by ADP alone or in combination with adrenaline

Eur J Pharmacol. 1990 Oct 23;187(3):541-5. doi: 10.1016/0014-2999(90)90384-i.

Abstract

Cloricromene may inhibit platelet activation induced by several agonists. In this study we report that ADP and adrenaline synergistically promote platelet aggregation and cytoplasmic Ca2+ movements in aequorin-loaded platelets. Cloricromene caused dose-dependent reduction in platelet aggregation and cytoplasmic Ca2+ movements after exposure of the cells to a low concentration of ADP (2 microM) or to a combination of ADP (2 microM) and adrenaline (10 microM). Cloricromene's inhibitory action may be of considerable pharmacological interest since platelet activation by a combination of agonists may mimic the conditions under which thrombosis occurs in vivo.

MeSH terms

  • Adenosine Diphosphate / antagonists & inhibitors*
  • Adenosine Diphosphate / pharmacology
  • Aequorin / pharmacology
  • Calcium / blood
  • Chromonar / analogs & derivatives*
  • Chromonar / pharmacology
  • Cytoplasm / drug effects
  • Cytoplasm / metabolism
  • Drug Synergism
  • Epinephrine / antagonists & inhibitors*
  • Epinephrine / pharmacology
  • Humans
  • In Vitro Techniques
  • Platelet Aggregation / drug effects
  • Platelet Aggregation Inhibitors*

Substances

  • Platelet Aggregation Inhibitors
  • Aequorin
  • Adenosine Diphosphate
  • cloricromen
  • Chromonar
  • Calcium
  • Epinephrine